Each year, the U.S. spends $200B on healthcare costs for the 6.7 million Americans with dementia. The most unfortunate part of this statistic is that most of those patients don’t receive the care they need. Patients are often hospitalized because symptoms are not detected early enough nor reported accurately, and caregivers lack the skills and knowledge to provide the care they need. Thus, most dementia care is reactive, incurring significant unnecessary costs.

To address this challenge, Ceresti Health has developed their Caregiver-Enabled Dementia Program: a technology-enabled, scalable, and proprietary approach to dementia care that reduces hospitalizations by more than 50% and total cost of care by more than 30% by focusing on prevention, early detection, and early action. Currently Medicare Advantage health plans and providers are not equipped to engage with family caregivers, i.e., spouses or adult children who provide care for a loved one. Ceresti’s program solves this problem.

Ceresti’s program is easy to implement, and for traditional Medicare beneficiaries, payment comes directly from the Centers for Medicare & Medicaid Services (CMS) under their new GUIDE program. Estimates put the total addressable market for their program at $17B. Ceresti is currently generating revenue and catalyzed by the GUIDE model, expects 2025 to be a break-out year with revenue projected to increase more than 5x, with ARR greater than $10M.

Join our Fireside Chat with Ceresti Co-Founder and CEO, Dirk Soenksen, to hear how the company, catalyzed by the GUIDE model, expects 2025 to be a break-out year with revenue projected to increase more than 5x, with ARR greater than $10M.